Thiazolyl-Methylthio-1,3,4-Thiadiazole Hybrids as Halicin Analogues with Antimicrobial and Antibiofilm Activities: Chemical Development, Biological Assessment, and 2D-QSAR Study
Antibiotics · 29.04.2026 · 15 (5) · 448
DOI: 10.3390/antibiotics15050448 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antibiotics, online erschienen am 29.04.2026. Verfasst von Daniel Ungureanu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Iuliu Hațieganu University of Medicine and Pharmacy, Ministry of Education, Ministry of Investments and European Projects.
Abstract (Originalsprache)
Background/Objectives: The purpose of this study was the chemical design, synthesis, and evaluation of the antimicrobial and antibiofilm potentials of 20 novel thiazolyl-methylthio-thiadiazole hybrid compounds (6a–j and 8a–j).
Methods
The compounds were designed as structural analogues of halicin with two points of variation and were synthesized through a process with multiple condensation steps. The compounds were evaluated in vitro through MIC determinations for the antimicrobial activity and percentage of biofilm inhibition, and in silico, respectively, through molecular docking, druggability, and ADMETox prediction. A 2D-QSAR study was conducted for antimicrobial activity using the Free-Wilson model.
Results
In terms of antibacterial activity, all compounds displayed important activity on the tested strains (MICs = 15.62–250 μg/mL), except against Staphylococcus aureus. Regarding the antifungal activity, the effect against Candida albicans was similar to fluconazole in most cases (MIC = 15.62 μg/mL). With respect to the antibiofilm activity, the most effective activity was registered against the Pseudomonas aeruginosa biofilm. The in vitro results for the antibacterial activity against Escherichia coli were correlated with the observations drawn in the molecular docking study on the ATPase domain of the GyrB subunit of E. coli. The in silico predictions of the molecular properties concluded that all compounds have good druggability properties, while the ADMETox predictions concluded that the compounds could have low gastrointestinal absorption and blood–brain barrier permeation capacity, but raised safety flags (e.g., hepatotoxicity and high acute oral toxicity). The 2D-QSAR study concluded that the thiazolyl-methylthio-thiadiazole scaffold had the highest contribution to antimicrobial activity in almost all cases.
Conclusions
The two series of compounds highlight the impact of structural modulations of the scaffold and its substituents on the investigated biological activities.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania.
- Department of Organic Chemistry, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania.
- State Veterinary Laboratory for Animal Health and Safety, 1 Piața Mărăști Street, 400609 Cluj-Napoca, Romania.
- Institute of Life Sciences, University of Agricultural Sciences and Veterinary Medicine, 3-5 Calea Mănăștur, 400372 Cluj-Napoca, Romania.
- Faculty of Food Science and Technology, University of Agricultural Sciences and Veterinary Medicine, 3-5 Calea Mănăștur, 400372 Cluj-Napoca, Romania.
- Department of Pharmaceutical Technology and Biopharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania.
ORCID-Profile: Daniel Ungureanu, Gabriel Marc, Mihaela Niculina Duma, Dan Cristian Vodnar, Gheorghe-Adrian Martău, Laurian Vlase, Adrian Pîrnău, Brîndușa Tiperciuc, Cristina Moldovan, Anca Stana, Ilioara Oniga
Förderung
- Iuliu Hațieganu University of Medicine and Pharmacy
- Ministry of Education
- Ministry of Investments and European Projects
- “Iuliu Hațieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania
- MEC
- Installations and Special Objectives of National Interest (IOSIN), IZOSTAB
- National Multidisciplinary Research Centre of Excellence for Drug-Resistant Infections
Zitieren
APA
Ungureanu, D., Marc, G., Duma, M. N., Vodnar, D. C., Martău, G. A., Vlase, L., Pîrnău, A., Tiperciuc, B., Moldovan, C., Ionuț, I., Stana, A., Oniga, I., & Oniga, O. (2026). Thiazolyl-Methylthio-1,3,4-Thiadiazole Hybrids as Halicin Analogues with Antimicrobial and Antibiofilm Activities: Chemical Development, Biological Assessment, and 2D-QSAR Study. Antibiotics, 15(5), 448. https://doi.org/10.3390/antibiotics15050448
Vancouver
Ungureanu D, Marc G, Duma MN, Vodnar DC, Martău GA, Vlase L, et al. Thiazolyl-Methylthio-1,3,4-Thiadiazole Hybrids as Halicin Analogues with Antimicrobial and Antibiofilm Activities: Chemical Development, Biological Assessment, and 2D-QSAR Study. Antibiotics. 2026;15(5):448. doi:10.3390/antibiotics15050448
BibTeX
@article{Ungureanu2026,
author = {Ungureanu, Daniel and Marc, Gabriel and Duma, Mihaela Niculina and Vodnar, Dan Cristian and Martău, Gheorghe-Adrian and Vlase, Laurian and Pîrnău, Adrian and Tiperciuc, Brîndușa and Moldovan, Cristina and Ionuț, Ioana and Stana, Anca and Oniga, Ilioara and Oniga, Ovidiu},
title = {Thiazolyl-Methylthio-1,3,4-Thiadiazole Hybrids as Halicin Analogues with Antimicrobial and Antibiofilm Activities: Chemical Development, Biological Assessment, and 2D-QSAR Study},
journal = {Antibiotics},
year = {2026},
volume = {15},
number = {5},
pages = {448},
doi = {10.3390/antibiotics15050448}
}
EUVIMED